Acute visual loss during pregnancy after bromocriptine-induced ovulation. The elusive tumor.
The evaluation of patients complaining of amenorrhea with or without galactorrhea has been greatly enhanced by the availability of serum prolactin determinations and advances in diagnostic radiology. Likewise, the treatment of these patients with ergot derivative has resulted in the return of normal menses, and many pregnancies have been reported. The present report is of a patient with hyperprolactinemic amenorrhea-galactorrhea successfully treated with bromocriptine. A pregnancy followed resumption of menses, and a suprasellar cromophobeadenoma became manifest by producing blindness of the patient. The case is presented with recommendations for diagnosis and treatment.
D000208:Acute Disease; D000238:Adenoma, Chromophobe / Q000150:complications* / Q000175:diagnosis; D000568:Amenorrhea / Q000188:drug therapy; D001971:Bromocriptine / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D005687:Galactorrhea / Q000188:drug therapy; D006801:Humans; D010062:Ovulation Induction; D010911:Pituitary Neoplasms / Q000150:complications* / Q000175:diagnosis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000209:etiology*; D011388:Prolactin / Q000097:blood; D014786:Vision Disorders / Q000209:etiology*; D014792:Visual Acuity
D001971:Bromocriptine; D011388:Prolactin